Can I take chlorzoxazone while I am taking 2 mg of tizanidine?

Combining Chlorzoxazone with Tizanidine: Exercise Extreme Caution

You should generally avoid combining chlorzoxazone with tizanidine 2 mg due to the significant risk of additive central nervous system (CNS) depression, particularly excessive sedation, hypotension, and bradycardia. If you must use both medications together, close monitoring is essential and dose reduction should be strongly considered.

Primary Safety Concerns

Additive CNS Depression

Both medications are skeletal muscle relaxants that cause central nervous system depression, and their effects are additive when combined 1:

• Sedation is the most consistent adverse effect across all muscle relaxants 1
• The FDA label for tizanidine explicitly warns that "sedation may be additive when tizanidine is taken in conjunction with drugs (baclofen, benzodiazepines) or substances (e.g., alcohol) that act as CNS depressants" 2
• While chlorzoxazone is not specifically mentioned in the tizanidine label, it falls into the same category of CNS depressant muscle relaxants 3

Cardiovascular Risks with Tizanidine

Even at your low dose of 2 mg tizanidine, significant cardiovascular effects can occur 1:

• Hypotension and bradycardia are dose-dependent adverse effects of tizanidine 1
• Case reports document severe bradycardia (heart rate 30 bpm) and syncope with tizanidine monotherapy at 2 mg 4
• The Mayo Clinic consensus states tizanidine should be avoided in elderly patients due to "significant sedative and hypotensive effects" 1

Hepatotoxicity Considerations

Both medications carry hepatotoxicity warnings, though generally reversible 3:

• Chlorzoxazone is associated with hepatotoxicity that is "generally reversible and usually not serious" 3
• Tizanidine similarly carries hepatotoxicity warnings 3
• Combined use theoretically increases hepatic stress, though no specific interaction data exists

Lack of Pharmacokinetic Interaction Data

Importantly, there is no documented pharmacokinetic interaction between these two medications 5, 6:

• Chlorzoxazone is primarily metabolized by CYP2E1 5, 6
• Tizanidine is primarily metabolized by CYP1A2 7, 8, 9
• These different metabolic pathways mean they do not significantly affect each other's drug levels 2

However, the absence of pharmacokinetic interaction does not eliminate the pharmacodynamic risk of additive CNS and cardiovascular depression.

Clinical Recommendations

If You Must Use Both Medications:

1. Start with the lowest effective doses and monitor closely for excessive sedation, hypotension (systolic BP <90 mmHg), and bradycardia (HR <60 bpm) 1

2. Avoid activities requiring alertness such as driving or operating machinery, as the sedation is additive 2

3. Monitor blood pressure and heart rate regularly, especially during the first few weeks of combination therapy 1

4. Avoid alcohol and other CNS depressants completely while on this combination 2

5. Consider dose reduction of one or both agents if you experience dizziness, excessive drowsiness, or orthostatic symptoms 1

Alternative Approaches:

• Sequential dosing: Take medications at different times of day to minimize peak concentration overlap 3
• Single agent optimization: Consider maximizing the dose of one muscle relaxant before adding a second 3
• Alternative therapies: Physical therapy, NSAIDs, or other non-muscle relaxant options may be safer 3, 10

Common Pitfalls to Avoid

• Underestimating the 2 mg tizanidine dose: Even low doses can cause significant hypotension and bradycardia, especially when combined with other CNS depressants 4
• Ignoring orthostatic symptoms: Dizziness upon standing may indicate dangerous hypotension requiring immediate dose adjustment 1
• Abrupt discontinuation: If you need to stop either medication after prolonged use, taper slowly to avoid withdrawal symptoms including rebound hypertension and tachycardia 2